Medicare Enrolled
Dr. Morhaf Ibrahim, MD
Cardiovascular Disease · Jacksonville, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ibrahim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ibrahim? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ibrahim
Dr. Morhaf Ibrahim is a cardiovascular disease in Jacksonville, FL, with 16 years in practice. Based on federal Medicare data, Dr. Ibrahim performed 11,984 Medicare services across 4,493 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ibrahim received a total of $14,755 from 40 pharmaceutical and/or device companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ibrahim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 5% volume in FL$ $14,755 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,984
Medicare services
Top 5% in FL for cardiovascular disease
4,493
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~749 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 2,521 | $0 | $1 |
| Hospital follow-up visit, moderate complexity | 1,692 | $63 | $140 |
| Hospital follow-up visit, high complexity | 1,272 | $95 | $200 |
| Office visit, established patient (30-39 min) | 1,090 | $92 | $215 |
| Electrocardiogram (EKG), 12-lead | 611 | $11 | $34 |
| Echocardiogram, transthoracic | 462 | $123 | $426 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 459 | $25 | $70 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 449 | $18 | $55 |
| Critical care, first 30-74 min | 362 | $171 | $450 |
| Remote pacemaker/defibrillator monitoring, 90 days | 349 | $15 | $50 |
| Ultrasound of both sides of head and neck blood flow | 257 | $138 | $350 |
| Remote pacemaker monitoring, 90 days | 220 | $21 | $70 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 168 | $87 | $665 |
| Office visit, established patient, complex (40-54 min) | 149 | $130 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test | 144 | $41 | $106 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 131 | $26 | $135 |
| Initial hospital admission, high complexity | 129 | $139 | $400 |
| Programming of dual lead pacemaker system | 114 | $58 | $150 |
| EKG interpretation and report | 101 | $6 | $15 |
| Ultrasound of leg arteries or artery grafts | 93 | $183 | $375 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 87 | $620 | $1,200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 84 | $330 | $970 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 84 | $48 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 72 | $2 | $50 |
| Repair of left upper heart chamber with implant with review by radiologist | 70 | $646 | $1,600 |
| New patient office visit (45-59 min) | 70 | $124 | $330 |
| Ultrasound of heart with probe in esophagus, with report | 68 | $84 | $390 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $14 | $80 |
| Initial hospital admission, moderate complexity | 65 | $104 | $270 |
| New patient office visit, complex (60-74 min) | 61 | $166 | $415 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 50 | $117 | $425 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 39 | $787 | $2,430 |
| Programming of heart rhythm stimulation after drug infusion | 33 | $66 | $340 |
| Hospital follow-up visit, low complexity | 32 | $40 | $80 |
| Ultrasound of heart, follow-up | 31 | $20 | $239 |
| Transitional care management services for problem of high complexity | 31 | $217 | $460 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 29 | $157 | $650 |
| Transitional care management services for problem of at least moderate complexity | 28 | $154 | $320 |
| Insertion of heart rhythm monitor under skin | 26 | $3,282 | $6,885 |
| Office visit, established patient (20-29 min) | 26 | $50 | $145 |
| Measurement of heart blood flow and respiration | 23 | $20 | $85 |
| External shock to heart to regulate heart beat | 20 | $86 | $225 |
| Critical care, each additional 30 minutes | 20 | $87 | $230 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 19 | $16 | $75 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 19 | $254 | $900 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $10 | $50 |
| Ultrasound scan of abdominal aorta | 14 | $103 | $230 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $322 | $1,120 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $38 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.9% high complexity
27.9% medium
59.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,755
Total received (2018-2024)
Avg $2,108/year across 7 years
Top 17% in FL for cardiovascular disease
40
Companies
397
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,782 (79.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,850 (19.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,052
2023$4,124
2022$1,569
2021$1,284
2020$522
2019$3,624
2018$1,579
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$4,280
Biosense Webster, Inc.
$3,436
Boston Scientific Corporation
$1,286
Novartis Pharmaceuticals Corporation
$800
BIOTRONIK INC.
$783
Medtronic Vascular, Inc.
$454
PFIZER INC.
$420
Merck Sharp & Dohme LLC
$403
Boehringer Ingelheim Pharmaceuticals, Inc.
$309
AstraZeneca Pharmaceuticals LP
$293
E.R. Squibb & Sons, L.L.C.
$279
Janssen Pharmaceuticals, Inc
$257
Medtronic, Inc.
$250
Philips Electronics North America Corporation
$176
Amgen Inc.
$166
AtriCure, Inc.
$141
Alnylam Pharmaceuticals Inc.
$103
CeloNova BioSciences, Inc.
$93
Kiniksa Pharmaceuticals International, plc
$77
Impulse Dynamics (USA) Inc.
$75
Merck Sharp & Dohme Corporation
$71
Venclose Inc.
$67
Philips North America LLC
$64
BioSig Technologies, Inc.
$64
Novo Nordisk Inc
$58
CVRx, Inc.
$55
Lexicon Pharmaceuticals, Inc.
$44
MEDICOMP INC
$27
Acutus Medical, Inc.
$26
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$24
Stryker Corporation
$24
Amarin Pharma Inc.
$23
Sobi, Inc
$22
BOSTON SCIENTIFIC CORPORATION
$22
Bard Peripheral Vascular, Inc.
$16
Kiniksa Pharmaceuticals, Ltd.
$15
ABIOMED
$14
CARDIVA MEDICAL, INC.
$13
iRhythm Technologies, Inc.
$13
Shockwave Medical, Inc
$11
Top 3 companies account for 61.0% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (CK4) MCOT · (CK7) Extended Holter · AMPLATZER AMULET · AMPLATZER PICCOLO · AMPLIA MRI QUAD CRT-D SURESCAN · ASSURITY · AVEIR · Achieve · Acticor · Acticor 7 VR-T DX · Advisa · Amplia MRI · Arcalyst · Arctic Front · Assurity Pacemaker · Azure · BIOMONITOR · Barostim Neo System · BioMonitor · CAMZYOS · CARDIOMEMS · CARTO 3 · CARTO 3 SYSTEM · COBALT DR MRI SURESCAN · Cardiac Mapping System · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · Carto 3 · Carto 3 System · CartoSound · Confirm Rx · ELIQUIS · EMBLEM · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVRSF · Edora · Edora 8 DR-T · FARXIGA · FORTIFY ASSURA · GALLANT · GENERAL TACHY · GENERAL THERAPIES · GENERAL - TACHY · GENERAL TACHY · GENERAL THERAPIES · Impella · JARDIANCE · LABSYSTEM PRO · LAUNCHER · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MITRACLIP · MODELS · Merlin Connectivity and Remote · Micra · MitraClip System · N/A · ONPATTRO · Optimizer · Optimizer Smart System · PERCLOSE PROGLIDE · PRADAXA · PURE EP SYSTEM · Pacemakers · RESONATE · RHYTHMIA · Repatha · Reveal LINQ · Rivacor · Rybelsus · S-ICD System Magnet · Solia · TEGSEDI · TELEPATCH CARDIAC MONITOR · VENASEAL · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Vascular Lithotripsy · VersaCross Access Solution · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $123 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
150
Per 100K population
14.9
County median income
$68,447
Nearest hospital
MAYO CLINIC
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ibrahim is a clinical cardiology specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (low-engagement, top 17%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ibrahim experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Ibrahim performed 2,521 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ibrahim receive payments from pharmaceutical companies?
Yes. Dr. Ibrahim received a total of $14,755 from 40 companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ibrahim's costs compare to other cardiovascular diseases in Jacksonville?
Dr. Ibrahim's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ibrahim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Jacksonville
Browse cardiovascular diseases in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology